Advertisement

Digestive Diseases and Sciences

, Volume 50, Issue 3, pp 509–513 | Cite as

Multifocal Gastric Carcinoid Tumor in a Patient with Pernicious Anemia Receiving Lansoprazole

  • Tan Attila
  • Raj Santharam
  • Dennis Blom
  • Richard Komorowski
  • Timothy R. KochEmail author
Case Report

Keywords:

carcinoid tumor stomach proton pump inhibitor gastrin. 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Modlin IM, Sandor A: An analysis of 8305 cases of carcinoid tumors. Cancer 79(4):813–829, 1997CrossRefPubMedGoogle Scholar
  2. 2.
    Thompson GB, van Heerden JA, Martin JK Jr, Schutt AJ, Ilstrup DM, Carney JA: Carcinoid tumors of the gastrointestinal tract: presentation, management, and prognosis. Surgery 98:1054–1063, 1985PubMedGoogle Scholar
  3. 3.
    Carney JA, Go VLW, Fairbanks VF, Moore SB, Alport EC, Nora FE: The syndrome of gastric carcinoid tumors and nonantral gastric atrophy. Ann Intern Med 99:761–766, 1983PubMedGoogle Scholar
  4. 4.
    Freston JW, Borch K, Brand SJ, Carlsson E, Creutzfeldt W, Hakanson R, Olbe L, Solcia E, Walsh JH, Wolfe MM: Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells. A review and analysis. Dig Dis Sci 40(Suppl 2):50S–62S, 1995PubMedGoogle Scholar
  5. 5.
    Havu N: Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion 35(Suppl 1):42–55, 1986PubMedGoogle Scholar
  6. 6.
    Solcia E, Rindi G, Havu N, Elm G: Qualitative studies of gastric endocrine cells in patients treated long-term with omeprazole. Scand J Gastroenterol Suppl 166:129–137, 1989PubMedGoogle Scholar
  7. 7.
    Haga Y, Nakatsura T, Shibata Y, Sameshima H, Nakamura Y, Tanimur M, Ogawa M: Human gastric carcinoid detected during long-term antiulcer therapy of H2 receptor antagonist and proton pump inhibitor. Dig Dis Sci 43:253–257, 1998PubMedGoogle Scholar
  8. 8.
    Modlin IM, Lye KD, Kidd M: A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem? Am J Gastroenterol 99:23–32, 2004PubMedGoogle Scholar
  9. 9.
    Hirschowitz BI, Griffith J, Pellegrin D, Cummings OV: Rapid regression of enterochromaffin-like cell gastric carcinoids in pernicious anemia after antrectomy. Gastroenterology 102:1409–1418, 1992PubMedGoogle Scholar
  10. 10.
    Bashir S, Gibril F, Ojeaburu JV, Asgharian B, Entsuah LK, Ferraro G, Crafa P, Bordi C, Jensen RT: Prospective study of the ability of histamine, serotonin, or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas. Aliment Pharmacol Ther 16:1367–1382, 2002PubMedGoogle Scholar
  11. 11.
    Freston JW: Clinical significance of hypergastrinaemia: relevance to gastrin monitoring during omeprazole therapy. Digestion 51(Suppl 1):102–114, 1992CrossRefPubMedGoogle Scholar
  12. 12.
    De Block CE, De Leeuw IH, Bogers JJ, Pelckmans PA, Ieven MM, Van Marck EA, Van Acker KL, Van Gaal LF: Autoimmune gastropathy in type 1 diabetic patients with parietal cell antibodies: histological and clinical findings. Diabetes Care 26:82–88, 2003PubMedGoogle Scholar
  13. 13.
    Kokkola A, Sjoblom SM, Haapiainen R, Sipponen P, Puolakkainen P, Jarvinen H: The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anemia. A prospective follow-up study. Scand J Gastroenterol 33:88–92, 1998PubMedGoogle Scholar
  14. 14.
    Bresky G, Mata A, Llach J, Ginis MA, Pellisi M, Soria MT, Fernandez-Esparrach G, Mondelo F, Bordas JM: Endoscopic findings in a biennial follow-up program in patients with pernicious anemia. Hepatogastroenterology 50:2264–2266, 2003PubMedGoogle Scholar
  15. 15.
    Modlin IM, Lye KD, Kidd M: Carcinoid tumors of the stomach. Surg Oncol 12:153–172, 2003CrossRefPubMedGoogle Scholar
  16. 16.
    Heah SM, Eu KW, Ooi BS, et al.: Tumor size is irrelevant in predicting malignant potential of carcinoid tumors of the rectum. Tech Coloproctology 5:73–77, 2001Google Scholar
  17. 17.
    Debelenko LV, Emmert-Buck MR, Zhuang Z, et al.: The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type H gastric carcinoids. Gastroenterology 113:773–781, 1997PubMedGoogle Scholar
  18. 18.
    Waldum HL, Sandvik AK, Idle JR: Gastrin is the most important factor in ECL tumorigenesis. Gastroenterology 114:1113–1114, 1998PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Tan Attila
    • 1
  • Raj Santharam
    • 1
  • Dennis Blom
    • 2
  • Richard Komorowski
    • 3
  • Timothy R. Koch
    • 1
    • 4
    Email author
  1. 1.Division of Gastroenterology & Hepatology, Department of MedicineMedical College of WisconsinMilwaukeeUSA
  2. 2.Department of SurgeryMedical College of WisconsinMilwaukeeUSA
  3. 3.Department of PathologyMedical College of WisconsinMilwaukeeUSA
  4. 4.Division of Gastroenterology & HepatologyMedical College of WisconsinMilwaukeeUSA

Personalised recommendations